Adjuvant therapy of melanoma.
Retsas
S
S
D000970:Antineoplastic Agents; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000401:mortality / Q000628:therapy*; D016019:Survival Analysis
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins